Clinical Correlation References

• 1) Adams EB, MacLeod JN, Amebic liver abscess and its complications, Medicine, 56, 325-33, 1977.
• 2) Beeson-McDermott, Textbook of Medicine, 14th Ed, Philadelphia, W B Saunders Co., 1975.
• 3) Conn and Conn, Current Diagnosis, 4th Ed, Philadelphia, W B Saunders Co., 1974.
• 4) Davidson I, Clinical Diagnosis by Laboratory Methods, 16th Ed, Philadelphia, W B Saunders Co., 1979.
• 5) Halstead JA, The Laboratory in Clinical Medicine, Philadelphia, W B Saunders Co., 1976.
• 6) Harrison TR, Principles of Internal Medicine, 5th Ed, McGraw-Hill Co., 1966.
• 7) Harrison TR, Principles of Internal Medicine, 13th Ed, McGraw-Hill Co., 1995.
• 8) Hoeprich FG, Infectious Diseases, 2nd Ed., Harper & Row, 1977.
• 9) Hurst J, Willis, Ed., The Heart, 4th Ed., McGraw-Hill Co., 1978.
• 10) Knochel JP, The pathophysiology and clinical characteristics of severe hypophosphatemia, Arch Intern Med, 137, 203-20, 1977.
• 11) Mahajan JR, et al, Significance of serum lactic dehydrogenase enzyme In hepatic amoebasis, Indian Med Res, 63, 1006-09, 1975.
• 12) Nardone DA, et al, Mechanisms in hypokalemia, clinical correlation, Medicine, 57, 435-46, 1978.
• 13) Underwood JC, et al, Persistant diarrhea and hypoalbuminemia associated with cytomegalovirus enteritis, Br Med J, 1029-30, 1976.
• 14) Wallach J, Interpretation of Diagnostic Tests, 2nd Ed., Little, Brown and Co., Boston, 1974.
• 15) Wallach J, Interpretation of Diagnostic Tests, 3rd Ed., Little, Brown and Co., Boston, 1978.
• 16) Williams JW, et al, Hematology, 2nd Ed., McGraw-Hill, 1977.
• 17) Adams JT, et al, Significance of an elevated serum amylase, Surgery, 63, 877-84, 1968.
• 18) Alvarez C, Ramos A, Lipids, lipoproteins and apoproteins in serum during infection, Clin Chem, 32-1, 142-5, 1986.
• 19) Bach C, et al, Abscences congenitale de B-lipoproteines une nouvelle observation, Arch Fr Pediatr, 24, 1093, 1967.
• 20) Beisel WR, Trace elements In infectious processes, Med Clin North Am, 60, 831, 1976.
• 21) Conde RG, A Serial study of coagulation XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia, Br J Obstet Gynaecol, 83, 636-9, 1976.
• 22) Dacie JV, (Ed) Secondary or Symptomatic Hemolytic Anemias, The Haemolytic Anemias, Grune & Stratton, New York, 908, 1967.
• 23) Delamore J W, et al, Haematological clues in systemic disease, Practitioner, 216, 27-36, 1976.
• 24) Eastham RD, Biochemical Values in Clinical Medicine, 5th Ed., William and Wilkins, 1975.
• 25) Fenuku R , et al, Serum albumin and total globulin levels in common liver diseases in Accra (Ghana), Trop Geogr Med, 30, 87-90, 1978.
• 26) Kowlessar OO, et al, Comparative study of serum leucine aminopeptidase, 5-nucleotidase and nonspecific alkaline phosphatase in disease affecting the pancreas, hepatobiliary and bone, Am J Med, 31, 231-7, 1961.
• 27) Lowe J R, Dixon J S, Guthrie J A, McWhinney P, Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis, Ann Rheum Dis, 45, 921-4, 1986.
• 28) Lum, et al, Serum gamma glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone, Clin Chem, 18, 358-62, 1972.
• 29) Narayan I, et al, Muscular dystrophy, Part 1, serum enzymes in the duchenne muscular dystrophy and neuromuscular disorders, Indian J Med Res, 62, 598-604, 1974.
• 30) Neale, et al, Effects of intrahepatic and extrahepatic infection on liver function, Br Med J, 1, 382-7, 1966.
• 31) Rayfield EJ, et al, Impaired carbohydrate metabolism during a mild viral illness, N Engl J Med, 289, 618, 1973.
• 32) Samter M, (Ed), Immunological Diseases, 3rd Ed., Little, Brown & Co., 1978.
• 33) Saoji A, et al, Electrophoresis and immuno electrophoresis in leprosy, Lepr India, 50, 161-5, 1978.
• 34) Searcy RL, Diagnostic Biochemistry, McGraw-Hill, 1969.
• 35) Skansberg P, Prognostic value of blood platelet counts, coagulation factors and serum fibrin/fibrinogen degredation products (FDP) in acute infection, Scand J Infect Dis, 10, 61-5, 1978.
• 36) Sleisenger MH, and Fortran JS, Gastrointestinal Disease, W.B. Saunders Co., Philadelphia, 1978.
• 37) Sterkel R L, et al, Serum isocitric dehydrogenase activity with particular reference to liver disease, J Lab Clin Med, 52, 176, 1975.
• 38) Swaroop AK, et al, Uric acid levels in neurological and psychiatric disorders, Neurol India, 24, 100-3, 1976.
• 39) Teloh HA, Serum proteins in hepatic disease, Ann Clin Lab Sci, 8, 127-8, 1978.
• 40) Wroblewski, The significance of alterations in serum enzymes in the differential diagnosis of jaundice, Arch Intern Med, 1, 313, 1958.
• 41) Agradi E, Messina V, Campanella G, et al, Hospital malnutrition incidence and prospective evaluation of general medical patients during hospitalization, Acta Vitaminol Enzymol, 6, 235-42, 1984.
• 42) Andersen T, McNair P, Hyldstrup L, et al, Secondary hyperthyroidism of morbid obesity regress during weight reduction, Metabolism, 37, 425-6, 1988.
• 43) Anonymous, Intravenous feeding with amino acids and fats, Drug Ther Bull, 10, 49, 1972.
• 44) Ashwell K, Hopton MR, Harrop JS, Serum free thyroxine concentrations in subjects with high circulating levels of thyroxine binding globulin, Ann Clin Biochem, 20, 285-8, 1983.
• 45) Baysal A, Johnson BA, Linkswiler H, Vitamin B6 depletion in man, blood vitamin B6 plasma pyridoxol phosphate, erum cholesterol, serum transaminase, J Nutr, 89, 19, 1966.
• 46) Bellon EM, Haemolytic anemia due to nalidixic acid, Lancet, 2, 691, 1965.
• 47) Blomfeld J, Dixon SR, McCredis DA, Potential hepatotoxicity of copper in recurrent heodialysis, Arch Intern Med, 128, 555, 1971.
• 48) Bogusz M, Influence of insecticides on the activity of some enzymes contained in human serum, Clin Chim Acto, 19, 367, 1968.
• 49) Borel GA, Ruedi B, Bringolf M, Magnenat P, Perturbations of liver fuction in obese patients during fast, Digestion, 5, 183, 1972.
• 50) Bork K, Korting GW, Faust G, Increase of certain serum enzyme levels (GOT, LDH, CPK, MK) after body massage and its significance on dermatomyositis, Klin Wochenschr, 50, 332, 1972.
• 51) Brody JM, Siebert WF, Cattau EL, Jr, et al, Detection of tissue injury after extracorporeal shockwave lithotripsy of gallstones, J Clin Gastroenterol, 13, 348-52, 1991.
• 52) Buzio C, Mutti A, Capani F, et al, Circadian rhythm of proteinuria effects on an evening meat meal, Nephrol Dial Transplant, 4, 266-70, 1989.
• 53) Campion EW, DeLabry LO, Glynn RJ, The effect of age on serum albumin in healthy males, report from the normative aging study, J Gerontol, 43, M18-20, 1988.
• 54) Chadwick SJD, Mowbray JF, Dudley HAF, Plasma fibronectin and complement in surgical patients, Br J Surg, 71, 718-20, 1984.
• 55) Chen CJ, Sikes CR, Dziewanowska ZE, et al, The influence of blood chemistry on T4 and FT4I in major depression, J Affect Disord, 20, 159-60, 1990.
• 56) Coen G, Mazzaferro S, Ballanti P, et al, Plasma insulin-like growth factor-I and bone formation parameters in predialysis chronic renal failure, Miner Electrolyte Metab, 17, 153-59, 1991.
• 57) Das I, Raised C-reactive protein levels in serum from smokers, Clin Chim Acta, 153, 9-13, 1985.
• 58) Deschamps JP, Lahrichi M, Biological values in the child and adolescent, Reference Values in Human Chemistry, Karger, 109, 1973.
• 59) Dubick MA, Conteas CN, Billy HT, et al, Raised serum concentrations of pancreatic enzymes in cigarette smokers, Gut, 28, 330-5, 1987.
• 60) Eastham RD, Biochemical Values in Clinical Medicine, 4th Ed., Williams and Wilkins, 1971.
• 61) Faierman D, Jacobs S, Liver injury from elixir of terpinhydrate with codeine, Mt Sinai J Med, 40, 56, 1973.
• 62) Filomena CA, Filomena AF, Huddock J, et al, Evaluation of serum immonoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange, Am J Clin Pathol, 98, 243-8, 1992.
• 63) Gidlow DA, Church JF, Clayton BE, Haematological and biochemical parameters in an industrial workforce, Ann Clin Biochem, 20, 341-8, 1983.
• 64) Gidlow DA, Church JF, Clayton BE, Seasonal variation in haematological and biochemical patterns, Ann Clin Biochem, 23, 310-6, 1986
• 65) Gleason MN, Gosslein RE, Hodge HC, Clinical Toxicology of Commercial Products, Williams and Wilkins, 1957.
• 66) Golik A, Rubio A, Weintraub M, et al, Elevated serum liver enzymes in obesity, a dilemma during clinical trials, Int J Obesity, 15, 797-801, 1991.
• 67) Goodman LS, Gilman A, The Pharmacological Basis of Therapeutics, 4th Ed., MacMillan Co., New York, NY, 1970.
• 68) Hansten PD, Drug Interactions, Lea and Febiger, Phailadelphia, PA, 1971.
• 69) Hennes HM, Smith DS, Schnider K, et al, Elevated liver transaminase levels in children with blunt abdominal trauma, a predictor of liver injury, Pediatrics, 86, 87-90, 1990.
• 70) Huang CM, Elin RJ, Ruddel M, et al, Changes in tests during and after alcohol abuse, Clin Chem, 36, 1168-9, 1990.
• 71) Huisman A, Aarnoudse JG, Fidler V, et al, Plasma viscosity during normal pregnancy, Clin Hemorheol, 9, 553-8, 1989.
• 72) Hulley SB, Vogel JM, Donaldson CL, et al, The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest, J Clin Invest, 50, 2506, 1971.
• 73) Jubiz W, Canterbury JM, Reiss E, Tyler FH, Circadian rhythm is serum parathyroid hormone concentration in human subjects, correlation with serum calcium, J Clin Invest, 51, 2040, 1972.
• 74) Karkkainen P, Poikolainen K, Salaspuro M, Serum B-hexosaminidase as a marker of heavy drinking, Alcohol Clin Exp Res, 14, 167-90, 1990.
• 75) Kashyap S, Schulze KF, Forsythe M, et al, Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk, Am J Clin Nutr, 52, 254-62, 1990.
• 76) Kauffman CA, Jones PG, Kluger MJ, Fever and malnutrition, endogenous pyrogen/interluken-1 in malnourished patients, Am J Clin Nutr, 44, 449-52, 1986.
• 77) Kelly PM, Bending MR, Barron JL, Comparison of serum calcium fractions during hemodialysis and peritoneal dialysis, Ann Clin Biochem, 24, 585-90, 1987.
• 78) Kotowicz MA, Melton LJ III, Cedel SL, et al, Effect of age on variables relating to calcium and phosphorus metabolism in women, J Bone Mineral Res, 5, 345-51, 1990.
• 79) Kristensson AA, Wallerstedt S, Ailing C, et al, Haematological findings in chronic alcoholics after heavy drinking with special reference to haemmolysis, Eur J Clin Invest, 16, 178-83, 1986.
• 80) Leonard PJ, The effect of age and sex on biochemical parameters in blood of healthy human subjects, Reference Values in Human Chemistry, G Siest, Ed, Karger 134, 1973.
• 81) Lester E, Serum enzyme level in healthy old people, Ann Clin Biochem, 14, 118-9, 1977.
• 82) Leteller G, Desjarlas F, Study of seasonal variations for eighteen biochemical parameters over a four-year period, Clin Biochem, 15, 206-11, 1982.
• 83) Liewendahl K, Tikanoja S, Mahonen H, et al, Concentrations of iodithyronines in serum of patients with chronic renal failure and other nonthyroidal illnesses, role of free fatty acids, Clin Chem, 33, 1382-86, 1967.
• 84) Lindholm J, Steiniche T, Rasmussen E, et al, Bone disorder in men with chronic alcoholism, a reversible disease? J Clin Endocrinol Metab, 73, 118-24, 1991.
• 85) McCance DR, Clarke KC, Kennedy L, Serum fructosamine in uremia, myeloma and acute inflammatory disorders - relationship to serum glucose and albumin levels, Ann Clin Biochem, 26, 63-8, 1989.
• 86) Misaki M, Shima T, Yano Y, et al, Serum transferrin as a marker of bone graowth in boys, correlation with serum alkaline phosphatase activity, plasma insulin growth factor-I and rate of growth in height, Horm Metab Res, 23, 230-2, 1991.
• 87) Moody BJ, Shakespeare PG, Batstone GF, The effects of septic complications upon the serum protein changes associated with thermal injury, Ann Clin Biochem, 22, 391-6, 1985.
• 88) Morgan DB, The impact of aging - present and future, Ann Clin Biochem, 20, 257-61, 1983.
• 89) Moser PB, Borel J, Majerus T, et al, Serum zinc and urinary zinc excretion of trauma patients, Nutr Res, 5, 253-61, 1985.
• 90) Orwoll ES, Meier DE, Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging, relationship to the development of senile osetopenia, J Clin Endocrinol Metab, 63, 1262-69, 1986.
• 91) Pestell RG, Hurley DM, Vandogen R, Biochemical and hormonal changes during a 1000 km ultramarathon, Clin Exp Pharmacol Physiol, 16, 353-61, 1989.
• 92) Porikos KP, Van Itallie TB, Diet induced changes in serum transaminase and triglyceride levels in healthy adult men, Role of sucrose and excess calories, Am J Med, 75, 624-30, 1983.
• 93) Rao TK, Nicastri AD, Friedman EA, Natural history of heroin-associated nephropathy, N Engl J Med, 290, 19, 1974.
• 94) Rehrer NJ, Brouns F, Beckers EJ, et al, Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running, Eur J Appl Physiol, 64, 1-8, 1992.
• 95) Rennie D, Frayser R, Gray G, Houston C, Urine and plasma proteins in men at 5400 m, J Appl Physiol, 32, 369, 1972.
• 96) Robinson D, Whitehead TP, Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening, Ann Clin Biochem, 26, 393-400, 1989.
• 97) Rosalki SB, Genetic influences on diagnostic enzymes in plasma, Enzyme, 39, 95-109, 1988.
• 98) Salspuro M, Characteristics of laboratory markers in alcohol-related organ damage, Scan J Gastrointesterol, 24, 769-80, 1989.
• 99) Senay LC Jr, Christensen ML, Changes in blood plasma during progressive dehydration, J Appl Physiol, 20, 1136, 1965.
• 100) Shakespeare PG, Ball AJ, Spurr ED, Serum protein changes after abdominal surgery, Ann Clin Biochem, 26, 49-57, 1989.
• 101) Wintrobe M M, et al, Clinical Hematology, 7th Ed, 1974.
• 102) Berner JJ, Effects of Disease on Laboratory Tests, J, B, Lippincott Co., New York, 1983.
• 103) Sigurdson, et al, Calcium absorption and excretion in the gut in acromegaly, Clin Endocrinol (OXF), 2, 187-92, 1973.
• 104) Harvey AM, et al, The Principles and Practice of Medicine, 19th Ed. Appleton-Century-Crofts, 1976.
• 105) Zuyderhoudt FM, et al, An enzyme linked immunoassay for ferritin in human serum and rat plasma and the influence of the iron in serum ferritin on serum iron measurement, during acute hepatitis, Clin Chim Acta, 86, 37-44, 1978.
• 106) Altomonte L, et al, Serum concentration of bile acids in the diagnosis of liver lesions in rheumatoid arthritis, Minerva Med, 73(24), 1695-1698, 1982
• 107) Foberg U, Fryden A, Kagedal B, Tobiasson P, Serum bile acids in gilbert’s syndrome, after oral load of chenodeoxycholic acid, Scan J Gastroenterol, 20, 325-9, 1985.
• 108) Rhoads CP, et al, Observations on Etiology and treatment of anemia associated with hookworm infestation, Medicine, 1934, 13, 317, 1934.
• 109) Top FH, Wehrele PP, Eds, Communicable and Infectious Diseases, 7th Ed, CV Mosby Co., St, Louis, 1972.
• 110) Lum, et al, Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone, Clin Chem, 18, 358-362, 1972.
• 111) Castaneda MR, Guerrero G, Studies on the leucocytic picture in brucellosis, J Infect Dir, 1946, 78, 43, 1946.
• 112) Hsieh KM, et al, Serum lactic dehydrogenase levels in various disease states, Proc Soc Exper Biol Med, 91, 626-630, 1956.
• 113) Gallagher, Seligson, Significance of abnormally low blood urea levels, N Engl J Med, 266, 492-5, 1962.
• 114) Wochos DN, et al, serum lipids in chronic renal failure, Mayo Clin Proc, 51, 660-4, 1976.
• 115) Wiener K, Plasma calcium in acute myocardial infarction, Ann Clin Biochem, 1977 14, 553-554, 1977.
• 116) Betro MG, Significance of increased alkaline phosphatase and lactate dehydrogenase activities coincident with normal serum bilirubin, Clin Chem, 18, 1427-1429, 1972.
• 117) Wiener K, Uraemia and hyperuricaemia in acute myocardial infarction, Clin Chim Acta, 73, 45-50, 1976.
• 118) Chaudhuri, et al, Study of serum lipids and enzymes in myocardial infarction and hypertension, Thromb Res, 1977 11, 163-70, 1977.
• 119) Auvinen, Evaluation of serum enzyme tests in the diagnosis of acute myocardial infarction, Acta Med Scand, 539, 7-70, 1972.
• 120) Garb S, Laboratory Tests in Common Use, 6th Ed, Springer, New York, 46-121, 1972.
• 121) Ledwich JR, Chest pain in the early recognition of large infarcts, Can Med Assoc J, 116, 38-43, 1977.
• 122) Fredrickson DS, The role of lipids in acute myocardial infarction, Circulation, 39-40 (Suppl 4), 99, 1969.
• 123) Dreyfuss F, The role of hyperuricemia in coronary heart disease, Dis Chest, 38, 332-334, 1960.
• 124) Doran GR, et al, Serum Creatine Kinas and adenylate kinase in thyroid disease, Clin Chim Acta, 35, 115, 1971.
• 125) Imrie CW, et al, Proceeding, Hypocalcemia of acute pancreatitis, The effect of Hypoalubinaemia, Br J Surg, 63, 662-3, 1976.
• 126) Rutenberg AM, et al, Serum gamma-glutyl transpeptidase activity in hepatobiliary pancreatic disease, Gastroenterology, 45, 43-8, 1976.
• 127) Weir GC, et al, The hypocalcemia of acute panreatitis, Ann Intern Med, 83, 185-9, 1975.
• 128) Zilva, JF Pannall P, Clinical Chemistry in Diagnosis and Treatment, 2nd Ed, Year Book Med Publ, Chicago, 1975.
• 129) Jones NF, et al, Hypoproteinemia in anaphylactoid purpura, Br Med J, 2, 1166, 1966.
• 130) Hedworth-Whitty, et al, Serum gamma-glutyl transpeptidase activity in myocardial ischemia, Br Heart J, 29, 432-8, 1967.
• 131) Cline MJ, Golde D, immune suppression of hematopoiesis, Am J Med, 64, 301-9, 1978.
• 132) Adams EC, Differentiation of myoglobin and hemoglobin in biological fluids, Ann Clin Lan Sci, 1971 1, 208, 1971.
• 133) Aisenberg AC, et al, Serum alkaline Phosphatase at the onset of hodgkin’s disease, Cancer, 26, 318, 1970.
• 134) Aiyathurai JE, et al, The probable significance of hypertriglyceridemia in viral hepatitis, Aust NZ J Med, 6, 529-32, 1976.
• 135) Skude G, et al, Amylase, Hepatic Enzymes, and bilirubin in serum of chronic alcoholics, Acta Med Scand, 201, 53-8, 1977.
• 136) Patel S, et al, Serum enzyme levels in alcoholism and drug dependency, J Clin Pathol, 28, 414-7, 1975.
• 137) MacGibbon BH, Mollin DL, Sideroblastic anaemia in man, observations on seventy cases, Br J Haematol, 11, 59, 1965.
• 138) Wallerstedt S, et al, Serum lipids and lipoproteins during abstinence after heavy alcohol consumption in chronic alcoholics, Scan J Clin Lab Invest, 37, 599-604, 1977.
• 139) Wadstein J, et al, Does hypokalaemia precede delirium tremens, Lancet, 2, 549-50, 1978.
• 140) Klinenber J R, Huperuricemia and gout, Med Clin North Am, 61, 299-312, 1977.
• 141) Ballantyne D, et al, Relationship of plasma uric acid to plasma lipids and lipoproteins in subjects with peripheral vascular disease, Clim Chim Acta, 70, 323-8, 1976.
• 142) Davignon J, et al, Plasma lipids and lipoprotein p[atterns in angiographically graded atherosclerosis of the legs and in coronary heart disease, Can Med Assc J, 116, 1245-50, 1977.
• 143) Castelli W, Garrison RJ, Wilson PWF, Incidence of coronary heart disease and lipoprotein cholesterol levels, JAMA, 256, 2835, 1986.
• 144) Najean Y, et al, Blood volume in health and disease, Clin Lab Haematol, 6, 543-64, 1977.
• 145) Karetzky MS, Blood studies in untreated patients with acute asthma, Am Rev Respir Dis, 112, 607, 1975.
• 146) Hsieh KM, et al, Serum lactic dehydrogenase levels in various disease states, Proc Soc Exper Biol Med, 91, 626-630, 1978.
• 147) Church JA, et al, Routine laboratory determinations in pediatric allergic disease, Ann Allergy, 41, 136-9, 1978.
• 148) Horn BR, et al, Total eosinophil counts in the management of bronchial asthma, N Engl J Med, 292, 1152- 5, 1975.
• 149) Harter AM, et al, Serum uric acid levels in patients with bronchial asthma, J Allergy Clin Immunol, 42, 88, 1968.
• 150) Ekberg MR, et al, Significance of increased factor VIII in early glomerulonephritis, Ann Intern Med, 83, 337-41, 1975.
• 151) Pelletier LL, et al, Infective endocarditis, A preview of 125 cases from the University of Washington hospitals, 1963-1972, Medicine, 56, 287-313, 1977.
• 152) Juengst D, et al, Urinary cholesterol exretion in men with benign prostatic hyperplasia and carcinoma of the prostate, Cancer, 43, 353-9, 1979.
• 153) Somers K, Folwer JN, Endomyocardial fibrosis, Clinical diagnosis, Cardiologia, 52, 25, 1968.
• 154) Spiro HM, Clinical Gastroenterology, 1st Edition New York, MacMillan, 1970.
• 155) Ihde DC, et al, Clinical manifestations of hepatoma, Am J Med, 56, 83-94, 1974.
• 156) Reynolds TB, et al, Lupoid hepatitis, Ann Intern Med, 61, 650, 1964.
• 157) Feher J, et al, Serum lipids and Lipoproteins in chronic liver disease, Acta Med Acad Sci Hung, 33, 217-23, 1975.
• 158) Mackay IR, Chronic hepatitus, Effect of prolonged suppresive treatment and comparison of azathioprine with prednisolone, Q J Med, 37, 379, 1968.
• 159) Snape WJ, et al, Marked alkaline phosphatase elevation with partial common bile duct obstruction due to calcific pancreatitis, Gastroenterology, 70, 70-73, 1976.
• 160) Heuck CC, et al, Serum lipids in renal insufficiency, Am J Clin Nutr, 31, 1547-53, 1978.
• 161) Loge JP, et al, Characterization of anemia associated with chronic renal insufficiency, Am J Med, 24, 4, 1958.
• 162) Kaye JP, et al, Plasma lipids in patients with chronic renal failure, Clin Chim Acta, 44, 301-5, 1973.
• 163) Frohlich J, et al, Carbohydrate metabolism in renal failure, Am J Clin Nutr, 31, 1541-6, 1978.
• 164) Lichtman MA, Miller DR, Eruthrocyte glycolysis, 2,3-DPG and ATP concentrations in uremic subjects, J Lab Clin Med, 76, 267, 1970.
• 165) Bagdade JD, et al, Hypertriglyceridemia - a metabolic consequence of chronic renal failure, N Engl J Med, 279, 181, 1968.
• 166) Woodbury J, et al, Cerebrospinal fluid and serum levels of magnesium, zinc and calcium in man, Neurol, 18, 700, 1968.
• 167) Meyer MS, et al, Low levels of serum calcium, phosphorous and plasma 25-hydroxy vitamin D in cirrhosis of the liver, Isr J Med Sci, 14, 725-30, 1978.
• 168) Kimber C, et al, The mechanism of anemia in chronic liver disease, Q J Med, 34, 33, 1965.
• 169) Sheehy TW, Berman A, The anemia of cirrhosis, J Lab Clin Med, 56, 72, 1960.
• 170) Wroblewski, The clinical significance of alterations in lactic dehydrogenase activity of body fluids, Am J Med Sci, 234, 301-312, 1957
• 171) Stanbury JB, et al, The Metabolic Basis of Inherited Disease, McGraw Hill, New York, 3rd edition, 1972.
• 172) Senay LC Jr, Christensen ML, Changes in blood plasma during progressive dehydration, J Appl Physiol, 20, 1136, 1965.
• 173) Bohan A, et al, A computer assisted analysis of 153 patients with polymyositis and dermatomyositis, Medicine, 56, 255-285, 1977.
• 174) Pearson CM, Bohan A, The spectrum of polyarteritis and dermatomysitis, Med Clin North Am, 61, 439-51, 1977.
• 175) Hoosmand H, et al, the use of serum lactate dehydrogenase isoenzymes in the diagnosis of muscle diseases, Neurol, 19, 26-31, 1969.
• 176) Goldberg DM, et al, Elevation of serum alkaline phosphatase activity and related enzymes in diabetes mellitus, Clin Biochem, 10, 8-11, 1977.
• 177) Belfiore F, et al, Serum enzymes in diabetes mellitus, Clin Chem, 19, 447, 1973.
• 178) Williams RH, Textbook of endocrinology, 5th Ed Philadelphia, WB Saunders, 1974.
• 179) Chase HP, et al, Juvenile Diabetes Mellitus and serum lipids and lipoprotein levels, Am J Dis Child, 130, 1113-7, 1976.
• 180) Haugen HN, Glucose and acetone as sources of error in plasma creatinine determinations, Scand J Clin Invest, 6, 17-21, 1954.
• 181) Martin JV, et al, The association between serum triglycerides and gamma glutamyl transpeptidase activity in diabetes mellitus, Clin Biochem, 9, 208-11, 1976.
• 182) Goldborg, et al, A method for the determination of gamma glutamyl traspeptidase in human serum, Enzymatic activity in health and disease, Gastroenterology, 44, 127-33, 1963.
• 183) Cattaneo R, et al, Peripheral T-Lymphocytes in juvenile-onset diabetics (JOD) and in maternity-onset
• diabetics (MOD), Diabetes, 25, 223-6, 1976.
• 184) Mikkelson WM, The possible association of hyperuricemia and/or gout with diabetes mellitus, Arthritis Rheum, 8, 853-9, 1965.
• 185) Kreisberg RA, Diabetic ketoacidosis, New concepts and trends in pathogenesis and treatment, Ann Intern Med, 88, 681-95, 1978.
• 186) Padova J, et al, Hyperuricemia in diabetic ketoacidosis, N Engl J Med, 267, 530-4, 1962.
• 187) Bottger D, Prognostic significance of lymphopenia in pulmonary sarcoidosis, Z Erkrank Atm-Org, 149, 197-201, 1977.
• 188) Withers KL, Leukaemoid reactions in disseminated non-reactive tuberculosis, A review of the literature with report of a case, Med J Aust, 2, 142, 1964.
• 189) Hoffbrand AV, et al, Megaloblastic anaemia in myelosclerosis, Q J Med, 37, 493, 1968.
• 190) Richter, et al, Acute myoglobinuria associated with heroin addiction, JAMA, 216, 1172-6, 1971.
• 191) Morrison JC, et al, Enzyme levels in the serum and cerebrospinal fluid in eclampsia, Am J Obstet Gynecol, 110, 619-24, 1971.
• 192) Burt RL, Combined and free plasma alpha-amino nitrogen in normal pregnancy and toxemia, Am J Obstet Gynecol, 1953, 65, 304, 1953.
• 193) Crisp WE, et al, Serum glutamic oxaloacetic transminase levels in the toxemias of pregnancy, Obstet Gynecol, 13, 487-97, 1959.
• 194) Eastman, Hellman, Obstetrics, 13th edition (Williams) Appleton-Century-Crofts New York, 1966.
• 195) Chesley LC, Hypertensive disorders in pregnancy, Appleton-Century-Crofts New York, 1978.
• 196) Bauer JD, et al, Bray's Clinical Laboratory Methods, 7th Edition, CV Mosby Co., St Louis, 1968
• 197) Eastham RD, Biochemical Values in Clinical Medicine, 4th Edition , Williams and Wilkins, Baltimore MD, 1975.
• 198) Schreiner GC, et al, Toxic nephropathy, Adverse renal effects caused by drugs and chemicals, JAMA, 191, 849, 1965.
• 199) Gold Gl, et al, Hyperuricemia associated with the treatment of acute leukemia, Ann Intern Med, 47, 428, 1957.
• 200) Sabin SA, Keller LB, et al, Pulmonary Disease In Clinical Internal Medicine, Little Brown and Company, 100-107, 1979
• 201) Salaka LA, Serum electrolytes in hypertension in Nigerians, Clin Chim Acta, 34, 105, 1971.
• 202) Preuss HG, et al, Ammonia metabolism in renal failure, Ann Intern Med, 65, 54-61, 1966.
• 203) Breckinridge A, Hypertension in Hyperuricemia, Proc R Soc, 59, 316-8, 1966.
• 204) Galteau MM, et al, Variation plasmatic enzymes produced by exercise, References Values in Human Chemistry G, Siest (ED), 223, 1973.
• 205) Poortmans JR, Serum protein determination during short exhaustive physical activity, J Appl Physiol, 30, 190, 1971.
• 206) Fawcett JR, et al, Variation of plasma electrolyte and total protein levels in the individual, BR Med J, 2, 582, 1956.
• 207) Keul J, Doll E, Intermittent exercise, Metabolites, PO2 and acid-base equilibrium in the blood, J Appl Physiol, 34, 220, 1973.
• 208) Caraway WT, Sources of error in clinical chemistry, Stand Meth Clin Chem, 5, 19, 1965.
• 209) Schnohr P, Enzyme concentrations in serum after prolonged physical exercise, Dan Med Bull, 21, 68-71, 1974.
• 210) Winstein S, Collection and preservation of specimens, Stand Meth Clin Chem, 5, 1, 1965.
• 211) Richterich R, Clinical chemistry theory and practice, Clin Chem, 1969.
• 212) Haralambie G, Biochemical changes in blood (at rest) induced by exercise and training, References Values In Human Chemistry G, Siest (Ed), 243, 1973.
• 213) Bellon Em, Haemolytic anemia due to nalidixic acid, Lancet, 2, 691, 1965.
• 214) Man, et al, The lipids of serum and liver inpatients with hepatic diseases, J Clin Invest, 64, 623-43, 1945.
• 215) Mistilis SP, et al, Plasma lipids in extra-hepatic biliary obstruction, Aust NZ J Med, 5, 540-3, 1975.
• 216) Fowler WM, Pearson CM, Diagnostic and prognostic significance of serum enzymes, II, Neurological Diseases other than muscular dystrophy, Arch Phys Med Rehabil, 45, 125, 1968.
• 217) Allott EN, McArdle B, Further observations on familial periodic paralysis, Clin Sci, 3, 229, 1938.
• 218) Van Demmelen CKV, Klassen CHL, Cyanocobalamin dependent depression on the serum alkaline phosphatase level in patients with pernicious anemia, N Engl J Med, 271, 541, 1964.
• 219) Westerman MP, et al, Hypocholesterolaemia and anaemia, Br J Hematol, 31, 87-94, 1975.
• 220) Bazzano, Effects of folic acid metabolism on serum cholesterol levels, Arch Intern Med, 124, 710-3, 1969.
• 221) Chanarin I, The Megaloblastic Anemias, FA Davis Co., Philadelphia, 1969.
• 222) Tesculescu D, et al, Ventilatory impairment and hypoxemia in chronic non-specific lung disease, Bull Eur Physiopathol Respir, 12, 735-45, 1976.
• 223) Heller P, et al, Enzymes in Anemia, A study of abnormalities of several enzymes of carbohydrate metabolism in the plasma and erythrocytes in patients with anemia, with preliminary observations of bone marrow enzymes, Ann Intern Med, 53, 898-913, 1963.
• 224) Lawson DH, et al, Early mortality in the megaloblastic anemias, Q J Med, 41, 1, 1972.
• 225) Chow D, et al, Laboratory diagnosis of Bence-Jones Proteinuria in a patient with plasma cell leukemia, Clin Chem, 81, 1683, 1975.
• 226) Chusid EL, Hirsch RL, Colcher H, Spectrum of Hypertrophic Gastropathy, Arch Intern Med, 114, 621-8, 1978.
• 227) Peters SP, et al, Gaucher’s disease, A review, Medicine, 56, 425-42, 1977.
• 228) Lorber M, Adult-type Gaucher’s disease, A secondary orderof iron metabolism, J Mt Sinai Hosp, 37, 404, 197.
• 229) Harris-Jones JN, Hyperuricemia and essential hypercholesterolemia, Lancet, 1, 857, 1957.
• 230) Feldman EB, Wallace SL, Hypertrigyceridemia in gout, Circulation, 29, 508, 1964.
• 231) Barlow KA, Hyperlipidemia in primary gout, Metabolism, 1968 17, 289, 1968.
• 232) Denborough, et al, Biochemical changes in malignant hyperpyrexia, J Clin Enocr, 1, 1137-8, 1970.
• 233) Anonymous, 52 factors that can affect blood glucose levels, Clin Toxicol, 4, 297, 1971.
• 234) Deschamps JP, Lahrichi M, Biological values in the child and adolescent, Reference Values in Human Chemistry, G Siest (Ed), 109, 1973.
• 235) Parsons V, et al, Use of dialysis in the treatment of renal failure in liver disease, Postgrad Med J, 51, 515-20, 1975.
• 236) Chattehee A, et al, Renal functional status and serum electrolyte changes in hepatic failure, J Assoc Physicians India, 25, 475-82, 1977.
• 237) Strickland GT, Lew M, Wilson’s disease - clinical laboratory manifestations in 40 patients, Medicine 54, 113-38, 1975.
• 238) Strickland GT, et al, Hypersplenism in Wilson’s disease, Gut, 13, 220, 1972.
• 239) Diess A, et al, Hemolytic anemia in Wilson’s disease, Ann Intern Med, 73, 413, 1970.
• 240) Wilson CB, et al, Glomerulonephritis, DM, 22, 18-27, 1976.
• 241) Gannsslen M, et al, Die hamolytische konstitution, Dtsch Klin Med, 1, 146, 1925.
• 242) Rinderknecht H, et al, Serum creatinine phosphokinase in acute pancreatitis, Clin Biochem, 3, 165-70, 1970.
• 243) Seip M, et al, Serum cholesterol and triglycerides in children with anemia, Scand J Haematol, 19, 503-8, 1977.
• 244) MacKinney AA, et al, Acertaining genetic carriers of hereditary spherocytosis by statistical analysis of multiple laboratory tests, J Clin Invest, 41, 554, 1962.
• 245) Arends T, et al, Serum proteins in Hodgkin’s disease and malignant lymphoma, Am J Med 1954, 16, 833, 1954.
• 246) Belliveau, et al, Liver enzymes and pathology in Hodgkin’s disease, Cancer, 34, 300-05, 1974.
• 247) Kabakow B, et al, Hypercalcemia in Hodgkin’s disease, N Engl J Med, 256, 59, 1967.
• 248) Reeves, et al, Differential diagnosis of hypercalcemia by the chloride phosphate ratio, Am J Surg, 130, 166-71, 1975.
• 249) Major RH, Leger LH, Markes eosinophilia in Hodgkin’s disease, JAMA, 112, 2601, 1939.
• 250) Cline MJ, Berlin, NJ, Anemia in Hodgkin’s disease, Cancer, 16, 526, 1963.
• 251) Douglas DM, Claireaux AE, Hodgkin’s Disease in childhood, Arch Dis Child, 28, 222, 1953.
• 252) Juul, Human plasma cholinesterase isoenzymes, Clin Chim Acta, 19, 205, 1968.
• 253) Hurst DW, Meyer OO, Giant follicular lymphoblastoma, Cancer, 14, 753, 1961.
• 254) Waldmann T, et al, Albumin metabolism in patients with lymphoma, J Clin Invest, 42, 171, 1963.
• 255) Mallette Le, et al, Primary hyperparathyroidism, Clinical and biochemical features, Medicine, 53, 127-146, 1974.
• 256) Rocher HD, et al, Diagnosis of primary and secondary hyperparathyroidism, World J Surg,1, 709-20, 1977.
• 257) Edmondson JW, et al, The relationship of serum ionized and total calcium in primary hyperparathyroidism, J Lab Clin Med, 87, 624-29, 1976.
• 258) Yendt, et al, Detection of primary hyperparathyroidism, with special reference to its occurrence in hypercalciuric females with normal or borderline serum calcium, Can Med Assoc J, 98, 331-336, 1968.
• 259) Howard and Thomas, Clinical disorders of calcium homeostasis, Medicine, 42, 25-45, 1963.
• 260) Christensson T, et al, Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidsm, Clin Chim Acta, 78, 411-5, 1977.
• 261) DeMoor, et al, Results obtained from 75 patients operated upon for hyperparathyroidism, Low cholesterol levels in overt primary hyperparathyroidism, Ann Endocrinol (Paris), 616-620, 1973.
• 262) Madsen SN, et al, Urinary cyclic amp relation to albumin-corrected serum calcium in healthy persons and patients with primary hyperparathyroidism, Acta Med Scand, 200, 195-99, 1976.
• 263) Mintz DH, et al, Hyperuricemia in hyperparathyroidsm, N Engl J Med, 266, 112-114, 1961.
• 264) Pitney WR, The tropical splenomegaly syndrome, Trans R Soc Trop Med Hyg, 62, 717, 1968.
• 265) Bishop CR, et al, Leukokinetic studies, XIV blood neutrophilkinetics in chronic steady state neutropenia, J Clin Invest, 50, 1678, 1971.
• 266) Kruskemper HL, et al, Serum enzyme activities in disorders of thyroid function, Germ Med Mth, 14, 55-58, 1969.
• 267) Anderson OO, et al, Glucose tolerance and insulin secretion in hyperthyroidism, Acta Endocrinol, 84, 578-87, 1977.
• 268) Nightingale S, et al, The haematology of hyperthroidism, Q J Med, 185, 35-47, 1978.
• 269) Urbaniak WJ, et al, Circulating lymphocyte subpopulationsin hashimoto’s thyroiditis, Clin Exp Immunol, 15, 345, 1973.
• 270) Maclean, et al, Serum-enzymes in relation to electrocardiographic changes in accidental hypothermia, J Clin Endocr, 2, 1266-1270, 1968.
• 271) Maclean, et al, Serum enzyme activities in accidental hypothermia and hypothermic myxoedema, Clin Chim Acta, 52, 197, 1974.
• 272) Friday KE, Childs MT, Tsunehara CH, et al, Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes, Diabetes Care, 12, 276-81, 1989.
• 273) Graig FA, et al, Serum creatine phosphokinase in thyroid disease, Metabolism, 12, 57-59, 1963.
• 274) Horton L, et al, the haematology of hypothyroidism, Q J Med, 45, 101-23, 1976.
• 275) Lew PD, Dayer JM, Wollhein CB, et al, Effect on leukotriene B4, prostaglandin and arachidonic acid on cytosolic-free calcium in human neutrophils, Febs Lett, 166, 44-8, 1984.
• 276) Donati RM, et al, Erythropoiesis in hypothyroidism, Proc Soc Exp Biol Med, 144, 78, 1973.
• 277) Rennie, et al, The clinical significance of serum transminase in infectious mononucleosis, complicated by hepatitis, N Engl J Med, 257, 547-53, 1957.
• 278) Krugman and Ward, Infectious Diseases, 5th Ed, Mosby, St. Louis, 1973.
• 279) Neumann, et al, Distinct alkaline phosphatase in serum of patient with lymphacetic leukemia and infectious mononucleosis, Science, 186, 151-3, 1974.
• 280) Shuster F, et al, Dissociation of serum bilirubin and alkaline phosphatase in infectious mononucleosis, JAMA, 209, 267-8, 1969.
• 281) Beveridge BR, et al, Hypochromic Anemia, Q J Med, 34, 135, 1965.
• 282) Kasper CK, et al, Clinical aspects of iron deficiency anemia, JAMA, 191, 359, 1965.
• 283) Voight D, et al, Uber die Blutkonzentrationen der leukozyten und thrombocyten ber eisenmangel, Blut (Berlin), 14, 267, 1967.
• 284) Rachelefsky GS, et al, Serum enzyme abnormalities in juvenille rheumatoid arthritis, Pediatrics, 58, 730-6, 1976.
• 285) Baum J, Juvenille arthritis, Am J Dis Child, 135, 557-60, 1981.
• 286) Sunderman FW, et al, Clinical applications of the fractionation of serum proteins by paper electrophoresis, Am J Clin Pathol, 27, 125-8, 1957.
• 287) Hilden M, et al, Studies on the serum lipids and lipoproteins in steatosis of the liver, Acta Med Scand, 198, 207-12, 1975.
• 288) Sinha S, et al, Serum calcium and magnesium in different types of leprosy, Lepr India, 50, 54-6, 1978.
• 289) Feigin RD, et al, Inappropriate secretion of antidiuretic hormone in children with bacterial meningitis, Am J Clin Nutr, 30, 1482-4, 1977.
• 290) Andreoli TE, Carpenter CT, Plum F, Smith LH, Cecil, Essentials of Internal Medicine, WB Saunders Company, 1986.
• 291) Jameson, et al, Changes in serum phosphate levels associated with intestinal infarction and necrosis, Sur Gyn and Obst, 140, 19-21, 1975.
• 292) Woodward HQ, Changes in blood chemistry associated with carcinoma metastatic to bone, Cancer, 6, 1219-27, 1953.
• 293) Chopia D and Clerken EP, Hypercalcemia and malignant disease, Med Clin North Am, 59, 229-39, 1977.
• 294) Bergsagel DE, et al, The treatment of plasma cell myeloma, Adv Cancer Res, 0, 311, 1967.
• 295) De Fronzo RA, et al, Renal function in patients with multiple myeloma, Medicine, 57, 151-66, 1978.
• 296) Kyle RA, Multiple Myeloma, Review of 869 cases, Mayo Clin Proc, 50, 29, 1975.
• 297) Rosen, B Multiple myeloma: A critical review, Med Clin North Am, 59, 379-86, 1975.
• 298) Davis PJ, Davis FB, Hyperthyroidism in patients over the age of 60, Medicine, 53, 161-81, 1974.
• 299) Scadding GK, Harvard CW, Pathogenesis and treatment of Myasthenia Gravis, Br Med J, 283, 1008-12, 1981.
• 300) Takacse-Nagay L, et al, Definition of clinical features and diagnosis of myelofibrosis, Clin Lab Haematol, 4, 291-308, 1977.
• 301) Masry BE, et al, LDH isoenzymes in some haemopoietic diseases, Haematologia (Budap), 7, 405-11, 1973.
• 302) Maldonado JE, Harlon DG, Monocytosis, A current appraisal, May Clin Proc, 40, 248, 1965.
• 303) Kwiterpovich, et al, Neonatal diagnosis of familial type II hyperlipoproteinaemia, J Clin Endocr, 1, 118-21, 1973.
• 304) Bierman, et al, Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas, and the leukemias, Cancer Res, 16, 660-7, 1957.
• 305) Blanchaer, et al, Plasma lactic dehydrogenase and phosphohexose isomerase in leukemia, Blood, 13, 245-57, 1958.
• 306) Stosic G, Vizic R, Kandic LJ, et al, The ferritin reference values determined by DELFIA method, Diag Lab, 27, Suppl. 59, 1991.
• 307) Kumar A, et al, Hypercalcemia in leukemia, Indian J Cancer, 13, 277-9, 1976.
• 308) Ballard HS, Marcus AJ, Hypercalcemia in chronic myelogenous leukemia, N Engl J Med, 282, 663, 1970.
• 309) Licht A, Rachmilewitz EA, Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia, Acta Haematol (Basel), 49, 182, 1973.
• 310) Marsh JC, Analysis of 106 patients with chronic myelocytic leukemia examined in the University of Utah hematology clinic, 1944-1963, Unpublished,
• 311) Witts LJ, et al, Chronic granulocytic leukemia, Comparison of radiotherapy and busulphan therapy, report of the medical research council working party for therapeutic trials in leukemia, Br Med J, 1, 201, 1968.
• 312) Blum D, et al, Serum enzymes in the neonatal period, Biol Neonate, 26, 53-7, 1975.
• 313) Massry SG, et al, Calcium metabolism in patients with nephrotic syndrome, Am J Clin Nutr, 31, 1572-80, 1978.
• 314) Lim P, et al, Serum ionized calcium in nephrotic syndrome, Q J Med, 69, 421-6, 1976.
• 315) Orlowski M, the role of gamma-glutamyl transpeptidaase in the internal diseases clinic, Arch Immunol Ther Exp (Warsz), 11, 1-61, 1963.
• 316) Singer FR, et al, hypercalcemia in reticulum cell sarcoma without hyperparathyroidism or skeletal metastases, Ann Intern Med, 78, 365, 1973.
• 317) Moses AM, Spencer H, Hypercalcemia in patients with malignant lymphoma, Ann Intern Med, 59, 531, 1963.
• 318) Waldvagel FA, et al, Osteomyelitis, A review of clinical features, therapeutic considerations and unusual aspects, N Engl J Med, 282, 198, 1970.
• 319) Dacie JV, The Haemolytic Anemias, Part IV, Grune & Stratton, New York, 1967.
• 320) Fitzpatrick TB, et al, (Ed), Dermatology in General Medicine, McGraw-Hill, 1971.
• 321) Wallentin L, et al, Studies on plasma lipid and phospholipid composition in pernicious anemia before and after specific treatment, Acta Med Scand, 201, 161-5, 1977.
• 322) Stein ID, et al, Lactate dehydrogenase in megaloblastic anemia, J Lab Clin Med, 74, 331-9, 1969.
• 323) Anderssen N, The activity of lactic dehydrogenase in megaloblastic anemia, Scan J Haematol, 1, 212, 1964.
• 324) Levitan R, et al, Serum enzyme activities in patients with polycythemnia and myelofibrosis, Cancer, 13, 1218, 1960.
• 325) Gilbert HS, et al, A study of histamine in myeloproliferative disease, Blood, 28, 795, 1966.
• 326) Berlin NJ, Diagnosis and classification of polycythemia, Semin Hematol, 12, 339, 1975.
• 327) Myerson Rm, Frumin AM, Hyperkalemia associated with the myeloproliferative disorders, Arch Intern Med, 106, 479, 1960.
• 328) Gilbert HS, et al, Plasma and urinary tract findings in myeloproliferative disorders, J Mt Sinai Hosp, 30, 185, 1963.
• 329) Yu TF, Secondary gout associated with myeloproliferative diseases, Arthritis Rheum, 8, 765, 1965.
• 330) Schelp FP, et al, Serum proteinase and other serum proteins in protein-energy malnutrition, Br J Nutr, 38, 31-8, 1977.
• 331) Kondo T, Hayakawa T, Shibata T, et al, Serum levels of pancreatic enzymes in lean and obese subjects, Int J Pancreatol, 3, 241-8, 1988.
• 332) Wall AJ, Kirsner JB, Ulcreative colitis and Chron’s disease of the colon, Symptoms, signs, and laboratory aspects, Inflammatory Bowel Disease, Lea & Febiger, 101, 1975.
• 333) Blacklow NR, Cukor, G, Viral gastroenteritis, N Engl J Med, 304, 397-406, 1981.
• 334) Thayer WR, et al, The subpopulations of circulating white blood cells in inflammatory bowel disease, Gastroenterology, 71, 379-84, 1976.
• 335) Bohannon J, Wu YS, White Y, et al, Total bilirubin, development of a new chemical method, Clin Chem, 37, 948, 1991.
• 336) Kane S, et al, Indices of granulocyte activity in inflammatory bowel disease, Gut, 15, 953-99, 1974.
• 337) Colbert BL, Reye’s syndrome, Hospital Medicine, 89, 1986.
• 338) Consensus Conference, Office for Medical Applications Research, National Institutes for Health - Diagnosis and treatment of Reye’s syndrome, JAMA, 246, 2441-4, 1981.
• 339) Ravel R, Clinical Laboratory Medicine, 4th Ed., Yearbook Medical Publishers, Inc., Chicago, 1984.
• 340) Horsfall FL, Tamm I, (Eds), Viral and Rickettsial Infections of Man, 4th Ed., Lippincott, Philadelphia, 1965.
• 341) Kusher JP, et al, Idiopathic refractory sideroblastic anemia, clinical and laboratory investigation of 17 patients and review of literature, Medicine, 50,139, 1961.
• 342) Schwartz MK, Interference in diagnostic biochemical procedures, Adv Clin Chem, 16, 1, 1973.
• 343) Selye H, The Stress of Life, 3rd Ed., McGraw-Hill, New York, 1978.
• 344) Taggart P, et al, Suppression by oxprenolol of adrenergic response to stress, Lancet, 2, 256, 1972.
• 345) Dalovisia JR, et al, Subacute Thyroiditis with increased serum alklaine phosphatase, Ann Intern Med, 88, 505-7, 1978.
• 346) Hurley JR, Thyroiditis, DM, 13-15, 35-8, 1977.
• 347) Kimberly RP, et al, Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus, Ann Intern Med, 89, 336-41, 1978.
• 348) Fries JF, The clinical aspects of systemic lupus erythematosus, Med Clin North Am, 61, 229-39, 1977.
• 349) Estes D, et al, The natural history of systemic lupus erythematosus by prospective analysis, Medicine, 39, 85, 1960.
• 350) Rees EG, et al, Serum proteins in systemic lupus erythematosus, Br Med J, 5155, 795, 1959.
• 351) Schulman LE, et al, Serologic abnormalities in systemic lupus erythematosus, J Chroni Dis, 16, 889, 1963.
• 352) Feinglass EJ, et al, Neuropsychiatric manifestations of systemic lupus erythematosus, Diagnosis, clinical spectrum and relationship to other features of the disease, Medicine, 55, 323-39, 1976.
• 353) Budman DR, Steinberg A, Hematologic Aspects of systemic lupuis erythematosus, Ann Intern Med, 86, 220-9, 1977.
• 354) Feinstein EJ, Rapaport SI, Acquired inhibitors of blood coagulation, Prog Haemostasis Thromb, 1, 75, 1972.
• 355) Inque T, Okamura M, Amatsu K, et al, Serum lactate dehydrogenase and its isoenzymes in lupus nephritis, Arch Intern Med, 146, 548, 1986.
• 356) Rivero SJ, et al, Lymphopenia in systemic lupus erythematosus, Clinical diagnostic and prognostic significance, Arthritis Rheum, 21, 295-305, 1978.
• 357) Kimbal HR, et al, Marrow granulocyte reserves in rheumatic diseases, Arthritis Rheum, 16, 345-52, 1973.
• 358) Copeland GD, et al, Systemic lupus erythematosus, A clinical report of 47 cases with pathologic findings in 18, Am J Med Sci, 236, 318, 1958.
• 359) Defronzo RA, et al, Impaired renal tubular potassium secretion in systemic lupus erythematosus, Ann Intern Med, 86, 268-71, 1977.
• 360) Schoenfeld Y, et al, Immunoglobulin changes in SLE, Clin Immunol Immunopathol, 39, 99-101, 1977.
• 361) Hill GS, et al, Systemic lupus erythematosus morphologic corellations with immunologic and clinical data at the time of biopsy, Am J Med, 64, 61-79, 1978.
• 362) Arcasoy A, Cavdar AO, Changes of trace minerals (serum iron, zinc, copper and magnesium) in thalassemia, Acta Haematol (Basel), 53, 341-6, 1975.
• 363) Pekarek RS, et al, Serum zinc, iron, copper concentrations during typhoid fever in man effect of chloramphenicol therapy, Clin Chem, 21, 528-32, 1975.
• 364) Desai M, et al, Lipids and lipoproteins in thalassemia major, Indian J Pediatr, 13, 663, 1976.
• 365) Male JB, Medicical Hematology, 2nd Ed., CV Mosby, St, Louis, 1962.
• 366) Ball GV, et al, Pathogenisis of hyperuricemia in saturnine gout, N Engl J Med, 280, 1199, 1959.
• 367) Lubran M, The effects of drugs on laboratory values, Med Clin North Am, 53, 211, 1969.
• 368) Scott R, et al, Hypercalcemia related to cadmium exposure, Urology, 11, 462-5, 1978.
• 369) Garb S, Clinical Guide to Undesirable Drug Interactions and Interferences, Spring Publishing, New York, 1971.
• 370) Hange FM, et al, Postarsphenamine jaundice, JAMA, 1940, 115, 263, 1940.
• 371) Pin Lim, et al, Elevated serum enzymes in patients with wasp/bee sting and their clinical significance, Clin Chim Acta, 66, 405-9, 1976.
• 372) Wroblewski, The clinical significance of alterations in transaminase activities of serum and other body fluids, Adv Clin Chem, 1, 313, 1958.
• 373) Weinstein AJ, Farkas S, serologic tests in infectious diseases, Clinical utility and interpretation, Med Clin North Am, 62, 1099-1118, 1978.
• 374) Craven A, Tornaghi G, Paganardi L, et al, Haemorheological changes in obesity, Study on blood viscosity, red cell viscosity, filtration index, plasma viscosity and fibrinogen, Minerva Med, 78, 899-906, 1987.
• 375) Jensen KB, et al, Albumin and IgG turnover in ulcerative colitis and Crohn’s disease, Plasma Protein Turnover, University Park Press, Baltimore, MD, 1974.
• 376) Raz R, et al, Serum and urinary uric acid in infectious hepatitis, Isr J Med Sci, 13, 1219-21, 1977.
• 377) Irani FA, et al, Serum lactic dehydrogenase in pneumonia, South Med J, 65, 858, 874, 1972.
• 378) Betro, et al, Hypophosphataesmia and Hyperphosphasemia in a hospital population, Br Med J, 1, 273-6, 1972.
• 379) Barzel US, et al, Renal ammonium excretion and urinary pH in idiopathic uric acid lithiasis, J Urol, 1, 91, 1964.
• 380) Golding PL, et al, Multisystem involvement in chronic liver disease, Studies on the incidence and pathogenesis, Am J Med, 56, 772, 1973.
• 381) Lapatsanis P, et al, Phosphaturia in Thalassemia, Pediatrics, 58, 885-92, 1976.
• 382) Murdoch JM, Smith CC, Hematological aspects os systemic disease, Infection, Clin Lab Haematol, 1, 619, 1972.

Home | About Us | News | Products | Information & Resources |  Contact Us

CellMate Wellness Systems 785 Southwood Blvd., #1 P.O. Box 4549 Incline Village, NV 89451 Phone: 775-832-8485 Fax: 775-832-8488 Company Information: info@carbonbased.com Web Site Comments: webmaster@carbonbased.com

Copyright © 1996-2002 Carbon Based Corporation. All rights reserved.

Last modified: April 16, 2002